PCM
Piermont Capital Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-14,919
| Closed | -$1.23M | – | 254 |
|
|
2016
Q2 | $1.23M | Buy |
14,919
+7,239
| +94% | +$597K | 0.32% | 116 |
|
|
2016
Q1 | $583K | Buy |
7,680
+280
| +4% | +$21.3K | 0.19% | 130 |
|
|
2015
Q4 | $595K | Buy |
7,400
+1,000
| +16% | +$80.4K | 0.19% | 125 |
|
|
2015
Q3 | $407K | Hold |
6,400
| – | – | 0.13% | 170 |
|
|
2015
Q2 | $450K | Buy |
+6,400
| New | +$450K | 0.14% | 179 |
|
|
2015
Q1 | – | Sell |
-44,700
| Closed | -$2.85M | – | 239 |
|
|
2014
Q4 | $2.85M | Sell |
44,700
-570
| -1% | -$36.3K | 1.01% | 31 |
|
|
2014
Q3 | $2.7M | Sell |
45,270
-3,670
| -7% | -$219K | 1.05% | 23 |
|
|
2014
Q2 | $2.62M | Buy |
48,940
+7,740
| +19% | +$414K | 1.02% | 39 |
|
|
2014
Q1 | $2.49M | Buy |
41,200
+920
| +2% | +$55.5K | 1.2% | 11 |
|
|
2013
Q4 | $2.14M | Buy |
+40,280
| New | +$2.14M | 1.07% | 24 |
|